Giorgio V. Scagliotti, MD, PhD

Dr. Giorgio Scagliotti on Taking a Targeted Approach to Immunotherapy in Lung Cancer

August 30th 2016

Dr. Scagliotti on Treating EGFR-Mutated Tumors with Afatinib

September 23rd 2013

Giorgio V. Scagliotti, MD, PhD, head, Thoracic Oncology Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Hospital, Orbassano, Italy, discusses treating epidermal growth factor receptor- (EGFR) mutated tumors with afatinib.

Dr. Scagliotti on Lung Cancer Treatment-Related Toxicities

August 7th 2013

Giorgio V. Scagliotti, MD, PhD, Head, from the University of Turin, Italy, discusses toxicities related to chemotherapy and surgery in patients with lung cancer.

Dr. Scagliotti on Targeted Therapies and Chemotherapy

August 31st 2012

Dr. Giorgio Scagliotti, from the University of Turin, San Luigi Hospital, on Combining Targeted Therapies With Chemotherapy for Lung Cancer Patients.

Dr. Scagliotti Gives 3 Important Lung Cancer Takeaway Points

October 27th 2011

Dr. Giorgio Scagliotti from the University of Turin Gives 3 Important Lung Cancer Takeaway Points

Dr. Scagliotti Discusses Elderly Lung Cancer Therapy

October 19th 2011

Dr. Giorgio Scagliotti from University of Turin Discusses Elderly Lung Cancer Therapy

Dr. Scagliotti on the Future of Multiple Gene Profiles

October 12th 2011

Dr. Giorgio Scagliotti from the University of Turin Discusses the Future of Multiple Gene Profiles

Dr. Scagliotti on Mechanisms of Resistance to EGFR TKIs

October 7th 2011

Dr. Giorgio V. Scagliotti from the University of Turin on Mechanisms of Resistance to EGFR TKIs

Dr. Scagliotti on the Benefits of EGFR Targeted Therapy

September 27th 2011

Dr. Giorgio Scagliotti from the University of Turin in Italy on EGFR Targeted Therapy Survival Benefits

Dr. Scagliotti Discusses EGFR Mutations in NSCLC

September 16th 2011

Dr. Giorgio Scagliotti from University of Turin Discusses EGFR Mutations in non-small cell lung cancer

Dr. Scagliotti on Tailored Treatment & Host Genomics

September 13th 2011

Dr. Giorgio Scagliotti from the University of Turin on Tailored Treatment and the Cancer Genome

Dr. Scagliotti Discusses the Future of Lung Cancer Therapy

September 8th 2011

Dr. Giorgio V. Scagliotti from the University of Turin Discusses the Future of Lung Cancer Therapy

Dr. Scagliotti on Personalizing Care With Pemetrexed

August 31st 2011

Dr. Giorgio V. Scagliotti from the University of Turin Discusses Personalizing Care With Pemetrexed